Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model.

Blanco JCG, Pletneva LM, McGinnes-Cullen L, Otoa RO, Patel MC, Fernando LR, Boukhvalova MS, Morrison TG.

Nat Commun. 2018 May 15;9(1):1904. doi: 10.1038/s41467-018-04216-6.

2.

Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection.

Patel MC, Pletneva LM, Boukhvalova MS, Vogel SN, Kajon AE, Blanco JCG.

Front Microbiol. 2017 Aug 31;8:1646. doi: 10.3389/fmicb.2017.01646. eCollection 2017.

3.

Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats.

Blanco JCG, Pletneva LM, Otoa RO, Patel MC, Vogel SN, Boukhvalova MS.

Vaccine. 2017 Jul 13;35(32):3951-3958. doi: 10.1016/j.vaccine.2017.06.009. Epub 2017 Jun 16.

4.

Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus).

Patel MC, Wang W, Pletneva LM, Rajagopala SV, Tan Y, Hartert TV, Boukhvalova MS, Vogel SN, Das SR, Blanco JC.

PLoS One. 2016 Nov 4;11(11):e0166336. doi: 10.1371/journal.pone.0166336. eCollection 2016.

5.

Novel strategies for targeting innate immune responses to influenza.

Shirey KA, Lai W, Patel MC, Pletneva LM, Pang C, Kurt-Jones E, Lipsky M, Roger T, Calandra T, Tracey KJ, Al-Abed Y, Bowie AG, Fasano A, Dinarello CA, Gusovsky F, Blanco JC, Vogel SN.

Mucosal Immunol. 2016 Sep;9(5):1173-82. doi: 10.1038/mi.2015.141. Epub 2016 Jan 27.

6.

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy.

Blanco JCG, Pletneva LM, Oue RO, Patel MC, Boukhvalova MS.

Vaccine. 2015 Oct 5;33(41):5371-5379. doi: 10.1016/j.vaccine.2015.08.071. Epub 2015 Aug 31.

7.

Novel drugs targeting Toll-like receptors for antiviral therapy.

Patel MC, Shirey KA, Pletneva LM, Boukhvalova MS, Garzino-Demo A, Vogel SN, Blanco JC.

Future Virol. 2014 Sep;9(9):811-829.

8.
9.

Agents that increase AAM differentiation blunt RSV-mediated lung pathology.

Shirey KA, Lai W, Pletneva LM, Finkelman FD, Feola DJ, Blanco JC, Vogel SN.

J Leukoc Biol. 2014 Dec;96(6):951-5. doi: 10.1189/jlb.4HI0414-226R. Epub 2014 Jul 9.

10.

A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology.

Blanco JC, Boukhvalova MS, Pletneva LM, Shirey KA, Vogel SN.

Vaccine. 2014 Mar 14;32(13):1495-500. doi: 10.1016/j.vaccine.2013.11.032. Epub 2013 Nov 16.

11.

Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology.

Shirey KA, Lai W, Pletneva LM, Karp CL, Divanovic S, Blanco JC, Vogel SN.

Mucosal Immunol. 2014 May;7(3):549-57. doi: 10.1038/mi.2013.71. Epub 2013 Sep 25.

12.

The TLR4 antagonist Eritoran protects mice from lethal influenza infection.

Shirey KA, Lai W, Scott AJ, Lipsky M, Mistry P, Pletneva LM, Karp CL, McAlees J, Gioannini TL, Weiss J, Chen WH, Ernst RK, Rossignol DP, Gusovsky F, Blanco JC, Vogel SN.

Nature. 2013 May 23;497(7450):498-502. doi: 10.1038/nature12118. Epub 2013 May 1.

13.

Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strains.

Blanco JC, Pletneva LM, Wan H, Araya Y, Angel M, Oue RO, Sutton TC, Perez DR.

J Virol. 2013 Feb;87(4):2036-45. doi: 10.1128/JVI.00638-12. Epub 2012 Nov 28.

14.

Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.

Rallabhandi P, Phillips RL, Boukhvalova MS, Pletneva LM, Shirey KA, Gioannini TL, Weiss JP, Chow JC, Hawkins LD, Vogel SN, Blanco JC.

mBio. 2012 Aug 7;3(4). pii: e00218-12. doi: 10.1128/mBio.00218-12. Print 2012.

15.

The effect of emotional stress on the expression of the α-ENaC gene mRNA in the kidney of hypertensive ISIAH rats.

Pylnik TO, Pletneva LS, Redina OE, Smolenskaya SE, Markel AL, Ivanova LN.

Dokl Biol Sci. 2011 Jul-Aug;439:201-3. doi: 10.1134/S0012496611040132. Epub 2011 Sep 28. No abstract available.

PMID:
21953222
16.

Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent.

Shirey KA, Pletneva LM, Puche AC, Keegan AD, Prince GA, Blanco JC, Vogel SN.

Mucosal Immunol. 2010 May;3(3):291-300. doi: 10.1038/mi.2010.6. Epub 2010 Mar 10.

17.
18.

Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.

Blanco JC, Pletneva LM, Wieczorek L, Khetawat D, Stantchev TS, Broder CC, Polonis VR, Prince GA.

Virol J. 2009 May 14;6:57. doi: 10.1186/1743-422X-6-57.

19.
20.

The antiviral potential of interferon-induced cotton rat Mx proteins against orthomyxovirus (influenza), rhabdovirus, and bunyavirus.

Stertz S, Dittmann J, Blanco JC, Pletneva LM, Haller O, Kochs G.

J Interferon Cytokine Res. 2007 Oct;27(10):847-55.

PMID:
17970694
21.

Co-infection of the cotton rat (Sigmodon hispidus) with Staphylococcus aureus and influenza A virus results in synergistic disease.

Braun LE, Sutter DE, Eichelberger MC, Pletneva L, Kokai-Kun JF, Blanco JC, Prince GA, Ottolini MG.

Microb Pathog. 2007 Nov-Dec;43(5-6):208-16. Epub 2007 Aug 3.

PMID:
17689046
22.

Interferon-inducible Mx gene expression in cotton rats: cloning, characterization, and expression during influenza viral infection.

Pletneva LM, Haller O, Porter DD, Prince GA, Blanco JC.

J Interferon Cytokine Res. 2006 Dec;26(12):914-21.

PMID:
17238834
23.

The American cotton rat: a novel model for pulmonary tuberculosis.

Elwood RL, Wilson S, Blanco JC, Yim K, Pletneva L, Nikonenko B, Samala R, Joshi S, Hemming VG, Trucksis M.

Tuberculosis (Edinb). 2007 Mar;87(2):145-54. Epub 2006 Sep 12.

PMID:
16973421
24.

The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.

Ottolini MG, Blanco JC, Eichelberger MC, Porter DD, Pletneva L, Richardson JY, Prince GA.

J Gen Virol. 2005 Oct;86(Pt 10):2823-30.

PMID:
16186238
25.

Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy.

Richardson JY, Ottolini MG, Pletneva L, Boukhvalova M, Zhang S, Vogel SN, Prince GA, Blanco JC.

J Immunol. 2005 Apr 1;174(7):4356-64.

26.

The cotton rat: an underutilized animal model for human infectious diseases can now be exploited using specific reagents to cytokines, chemokines, and interferons.

Blanco JC, Pletneva L, Boukhvalova M, Richardson JY, Harris KA, Prince GA.

J Interferon Cytokine Res. 2004 Jan;24(1):21-8.

PMID:
14980081
27.

Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats.

Blanco JC, Richardson JY, Darnell ME, Rowzee A, Pletneva L, Porter DD, Prince GA.

J Infect Dis. 2002 Jun 15;185(12):1780-5. Epub 2002 May 31.

PMID:
12085325
28.

Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.

Ourmanov I, Brown CR, Moss B, Carroll M, Wyatt L, Pletneva L, Goldstein S, Venzon D, Hirsch VM.

J Virol. 2000 Mar;74(6):2740-51.

29.

[Features of the course of different forms of hypertensive cerebral crises (clinico-electrographic correlations)].

Chukhrova VA, Lebedeva NV, Pletneva LV.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1982 Sep;82(9):19-23. Russian. No abstract available.

PMID:
7148236
30.

[Value of the de Kleyn symptom in diagnosing vertebro-basilar insufficiency].

Kalinovskaia IIa, Pletneva LV.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1979;79(1):17-23. Russian.

PMID:
760338
31.

[Clinical manifestations and vascular reactivity in patients with dyscirculatory encephalopathy].

Maksudov GA, Mashanova GA, Pletneva LV, Babenkova SB, Vlasenko IT.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1978;78(6):850-6. Russian.

PMID:
676611
32.

[Organization by stages of the treatment of children with rheumatism coming under dispensary observation].

Pletneva LE, Mindlin IaS, Maksakova EN, Korniushin MA.

Vopr Revm. 1976 Oct-Dec;(4):52-5. Russian. No abstract available.

PMID:
1021982
33.

[Case of extensive avulsion of the scalp].

Imamaliev AS, Pletneva LP.

Ortop Travmatol Protez. 1976 May;(5):58-9. Russian. No abstract available.

PMID:
1012669
34.

[Dynamics of disorders of water-salt metabolism in animals with high small intestine fistulas].

Bognitskaia TN, Petrova LD, Pletneva LP, Smirnova EA.

Eksp Khir Anesteziol. 1976;(1):43-5. Russian. No abstract available.

PMID:
1261468
35.

[Organization of medical service and the course of rheumatism in children].

Pletneva LE, Mindlin IaS.

Sov Zdravookhr. 1976;(6):23-6. Russian. No abstract available.

PMID:
1013767
36.

[Effectiveness of stage-by-stage treatment of children with rheumatism].

Pletneva LE.

Zdravookhr Ross Fed. 1975 Dec;(12):14-7. Russian. No abstract available.

PMID:
1231429
37.

[State of cerebral hemodynamics in chronic kidney diseases].

Gloriozova TG, Pletneva LV.

Klin Med (Mosk). 1975 Mar;53(3):41-3. Russian. No abstract available.

PMID:
1117681
38.

[State of the mucus membrane of the small intestine in upper intestinal fistulas].

Bognitskaia TN, Rudenskaia MV, Pletneva LP.

Arkh Patol. 1975;37(10):42-9. Russian.

PMID:
1225268
39.

[The state of cerebral arterial and venous tone in stage I and II hypertension].

Pletneva LV.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1973;73(6):858-64. Russian. No abstract available.

PMID:
4753599

Supplemental Content

Loading ...
Support Center